IPC Strengthens Viksit UP–Viksit Bharat Vision Through Strategic MoUs to - 23rd July 2026 - Ministry of Health and Family Welfare - Gazette Notification PDF
Issued by Ministry of Health and Family Welfare
Read or download the official PDF of this gazette notification issued by the Ministry of Health and Family Welfare on 23rd July 2026. Classified under Press Release.
Executive Summary & Key Takeaways
Executive Summary On 23 July 2026, the Indian Pharmacopoeia Commission (IPC) signed and renewed two Memoranda of Understanding (MoUs) with CSIR-CIMAP and DSMNRU to advance healthcare quality and scientific innovation. These agreements focus on the standardization of herbal medicines, quality assessment of assistive devices, and the development of inclusive pharmacovigilance modules. The initiative aims to support the "Viksit UP–Viksit Bharat" vision by establishing Uttar Pradesh as a center of excellence for pharmaceutical quality and safe healthcare products.
Key Points / Main Content
Collaboration with CSIR-CIMAP (Renewed MoU)
- Continues a strategic partnership focused on medicinal plant research.
- Prioritizes the standardization and quality evaluation of herbal medicines to ensure safety and efficacy.
Collaboration with DSMNRU (New MoU)
- Focuses on creating scientific protocols to assess the quality, safety, and performance of assistive devices used by persons with disabilities.
- Mandates the development of a pharmacovigilance training module in sign language.
- Aims to enhance medicine safety awareness and simplify adverse drug reaction (ADR) reporting for persons with disabilities.
Strategic and Regional Goals
- Strengthens institutional partnerships and scientific research standards within the healthcare sector.
- Supports the "Viksit UP–Viksit Bharat" vision by improving regional access to safe and effective healthcare products.
- Reaffirms IPC’s commitment to national healthcare priorities and capacity building.
Impact Analysis
Indian Pharmacopoeia Commission (IPC) Impact The IPC reinforces its role as a leader in scientific innovation and healthcare quality, expanding its influence into herbal medicine standards and inclusive pharmacovigilance. Action Required Collaborate with partner institutions to develop scientific protocols and training modules while overseeing the implementation of the MoUs.
CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) Impact The institute maintains its critical role in the national research framework for medicinal plants and herbal medicine quality evaluation. Action Required Conduct ongoing research and standardization activities as outlined in the renewed agreement.
Dr. Shakuntala Misra National Rehabilitation University (DSMNRU) Impact The university gains institutional support to establish quality standards for assistive devices and improves its ability to serve persons with disabilities through specialized communication tools. Action Required Provide expertise for the development of sign language-based training modules and assist in the creation of protocols for assistive devices.
Persons with Disabilities Impact This group will benefit from higher-quality assistive devices and better access to medicine safety information through tailored communication (sign language). Action Required Utilize the developed training modules to report adverse drug reactions and engage with enhanced healthcare safety resources.